Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Shares Outstanding (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Shares Outstanding for 3 consecutive years, with $192.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 10.26% year-over-year to $192.1 million, compared with a TTM value of $192.1 million through Dec 2025, up 10.26%, and an annual FY2025 reading of $192.1 million, up 10.26% over the prior year.
  • Shares Outstanding was $192.1 million for Q4 2025 at BrightSpring Health Services, up from $180.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $192.1 million in Q4 2025 and bottomed at $117.9 million in Q3 2023.
  • Average Shares Outstanding over 3 years is $157.3 million, with a median of $172.7 million recorded in 2024.
  • The sharpest move saw Shares Outstanding skyrocketed 47.85% in 2024, then increased 2.33% in 2025.
  • Year by year, Shares Outstanding stood at $117.9 million in 2023, then surged by 47.85% to $174.2 million in 2024, then increased by 10.26% to $192.1 million in 2025.
  • Business Quant data shows Shares Outstanding for BTSG at $192.1 million in Q4 2025, $180.7 million in Q3 2025, and $177.1 million in Q2 2025.